Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Degeneration | 6 | 2021 | 75 | 2.360 |
Why?
|
| Retina | 8 | 2022 | 252 | 2.050 |
Why?
|
| Eye Proteins | 8 | 2011 | 160 | 1.350 |
Why?
|
| Ocular Hypertension | 3 | 2022 | 43 | 1.130 |
Why?
|
| Optic Disk | 2 | 2022 | 37 | 1.020 |
Why?
|
| Retinal Ganglion Cells | 3 | 2021 | 72 | 0.970 |
Why?
|
| Sphingomyelin Phosphodiesterase | 4 | 2022 | 183 | 0.950 |
Why?
|
| Carrier Proteins | 7 | 2011 | 597 | 0.950 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2022 | 86 | 0.930 |
Why?
|
| Reperfusion Injury | 3 | 2016 | 320 | 0.900 |
Why?
|
| Retinaldehyde | 6 | 2011 | 115 | 0.900 |
Why?
|
| Ceramides | 3 | 2022 | 578 | 0.860 |
Why?
|
| Disease Models, Animal | 6 | 2016 | 2550 | 0.840 |
Why?
|
| Electroretinography | 10 | 2021 | 122 | 0.830 |
Why?
|
| Rhodopsin | 6 | 2016 | 135 | 0.760 |
Why?
|
| Mice, Knockout | 12 | 2021 | 1692 | 0.710 |
Why?
|
| Histone Deacetylases | 2 | 2016 | 99 | 0.610 |
Why?
|
| Vision, Ocular | 2 | 2010 | 68 | 0.590 |
Why?
|
| Desipramine | 1 | 2016 | 47 | 0.550 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2014 | 116 | 0.550 |
Why?
|
| Ischemic Preconditioning | 1 | 2016 | 31 | 0.530 |
Why?
|
| Neuroprotection | 1 | 2016 | 28 | 0.530 |
Why?
|
| Retinal Cone Photoreceptor Cells | 3 | 2011 | 74 | 0.530 |
Why?
|
| cis-trans-Isomerases | 7 | 2011 | 63 | 0.470 |
Why?
|
| Blotting, Western | 6 | 2021 | 954 | 0.470 |
Why?
|
| Histone Deacetylase 2 | 1 | 2013 | 7 | 0.450 |
Why?
|
| Hypertension | 1 | 2022 | 1535 | 0.430 |
Why?
|
| Retinal Rod Photoreceptor Cells | 3 | 2010 | 71 | 0.420 |
Why?
|
| Light | 2 | 2011 | 152 | 0.420 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2011 | 7 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 2791 | 0.360 |
Why?
|
| G-Protein-Coupled Receptor Kinase 1 | 1 | 2010 | 6 | 0.360 |
Why?
|
| Transducin | 1 | 2010 | 31 | 0.350 |
Why?
|
| Animals | 15 | 2021 | 20881 | 0.350 |
Why?
|
| Rod Opsins | 2 | 2008 | 59 | 0.330 |
Why?
|
| Blindness | 1 | 2008 | 22 | 0.310 |
Why?
|
| Intraocular Pressure | 2 | 2021 | 143 | 0.310 |
Why?
|
| Acyltransferases | 1 | 2008 | 40 | 0.300 |
Why?
|
| Cell Count | 3 | 2021 | 248 | 0.300 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2008 | 46 | 0.300 |
Why?
|
| Mice | 10 | 2015 | 8474 | 0.270 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2021 | 626 | 0.270 |
Why?
|
| Caspase 3 | 2 | 2016 | 233 | 0.240 |
Why?
|
| Histones | 2 | 2016 | 111 | 0.240 |
Why?
|
| Diterpenes | 4 | 2010 | 42 | 0.210 |
Why?
|
| Sphingomyelins | 1 | 2022 | 106 | 0.210 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2016 | 381 | 0.200 |
Why?
|
| Acetylation | 3 | 2016 | 94 | 0.190 |
Why?
|
| Ischemia | 1 | 2022 | 229 | 0.190 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 209 | 0.190 |
Why?
|
| Opsins | 2 | 2011 | 19 | 0.180 |
Why?
|
| Cell Death | 1 | 2021 | 329 | 0.180 |
Why?
|
| Proteins | 1 | 2003 | 474 | 0.170 |
Why?
|
| Astrocytes | 1 | 2021 | 270 | 0.160 |
Why?
|
| Dark Adaptation | 2 | 2011 | 39 | 0.160 |
Why?
|
| Cytokines | 1 | 2022 | 866 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2021 | 753 | 0.140 |
Why?
|
| Hydroxamic Acids | 2 | 2014 | 84 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 1174 | 0.140 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 659 | 0.130 |
Why?
|
| Phosphorylation | 2 | 2010 | 1200 | 0.130 |
Why?
|
| Optical Imaging | 1 | 2016 | 46 | 0.130 |
Why?
|
| Glaucoma | 1 | 2016 | 50 | 0.130 |
Why?
|
| Macular Degeneration | 1 | 2016 | 75 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 507 | 0.120 |
Why?
|
| Cataract | 1 | 2016 | 134 | 0.120 |
Why?
|
| Retinal Pigments | 2 | 2005 | 61 | 0.120 |
Why?
|
| Lysine | 1 | 2014 | 96 | 0.120 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2015 | 145 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1040 | 0.110 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2016 | 306 | 0.110 |
Why?
|
| Cell Survival | 2 | 2014 | 901 | 0.100 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2010 | 95 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 61 | 0.090 |
Why?
|
| Rats | 2 | 2016 | 5300 | 0.090 |
Why?
|
| Laminin | 1 | 2010 | 62 | 0.090 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2010 | 12 | 0.090 |
Why?
|
| Adaptation, Ocular | 1 | 2010 | 7 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 261 | 0.090 |
Why?
|
| Biophysics | 1 | 2010 | 41 | 0.090 |
Why?
|
| Proteoglycans | 1 | 2010 | 103 | 0.090 |
Why?
|
| Apoptosis | 1 | 2016 | 1641 | 0.080 |
Why?
|
| Photic Stimulation | 1 | 2010 | 229 | 0.080 |
Why?
|
| Aging | 1 | 2015 | 911 | 0.080 |
Why?
|
| Retinol-Binding Proteins | 1 | 2009 | 28 | 0.080 |
Why?
|
| Retinoids | 2 | 2016 | 122 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 236 | 0.080 |
Why?
|
| Collagen | 1 | 2010 | 636 | 0.070 |
Why?
|
| Hair Color | 1 | 2006 | 4 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2016 | 2689 | 0.070 |
Why?
|
| Pigmentation | 1 | 2006 | 12 | 0.070 |
Why?
|
| Isomerism | 1 | 2006 | 63 | 0.070 |
Why?
|
| Photoreceptor Cells | 1 | 2006 | 62 | 0.070 |
Why?
|
| Humans | 3 | 2022 | 68618 | 0.070 |
Why?
|
| Time Factors | 2 | 2005 | 4655 | 0.070 |
Why?
|
| Rats, Inbred BN | 2 | 2014 | 51 | 0.060 |
Why?
|
| Valproic Acid | 2 | 2014 | 93 | 0.060 |
Why?
|
| Pigments, Biological | 1 | 2003 | 15 | 0.060 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2003 | 28 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2003 | 155 | 0.050 |
Why?
|
| Calcium | 1 | 2005 | 929 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2003 | 1033 | 0.050 |
Why?
|
| Male | 3 | 2016 | 37321 | 0.040 |
Why?
|
| Lipofuscin | 1 | 2016 | 43 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 186 | 0.030 |
Why?
|
| Acetyltransferases | 1 | 2014 | 49 | 0.030 |
Why?
|
| Retinal Neurons | 1 | 2014 | 9 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 317 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2010 | 89 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 87 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2010 | 120 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 1330 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2010 | 304 | 0.020 |
Why?
|
| Visual Perception | 1 | 2009 | 124 | 0.020 |
Why?
|
| Female | 2 | 2014 | 38074 | 0.010 |
Why?
|